CUPERTINO, Calif., June 11 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it will present at the Sixth Annual
Biotechnology and Medical Technology Conference being held at the New York
Palace Hotel in New York City. Matthew J. Hogan, Chief Financial Officer,
will be presenting at the conference on June 14, 2007 at 2:30 p.m. Eastern
Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)
A live audio webcast of the presentation will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations.”
If you are unable to participate during the live webcast, the call will be
archived on DURECT’s website under Audio Archive in the “Investor Relations”
section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit
http://www.www.durect.com.
SOURCE DURECT Corporation
06/11/2007
CONTACT: Matthew J. Hogan, Chief Financial Officer of DURECT
Corporation, +1-408-777-4936; or Media, Jeremiah Hall, Senior Vice President
of Feinstein Kean Healthcare, +1-415-677-2700, jeremiah.hall@fkhealth.com, for
DURECT Corporation
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.www.durect.com